Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Xiao-Ting Hou
Institution:
Dalian University
Observed institutions:
City University of Hong Kong,
Yanbian University,
Dalian University,
Affiliated Zhongshan Hospital of Dalian University
ORCID:
0009-0002-0213-4494
Observed ORCID:
0009-0002-0213-4494
OpenAlex ID:
A5049512729
The role and mechanism of flavonoid herbal natural products in ulcerative colitis
2022
·
Jia-Chen Xue
, Shuo Yuan
, et al.
·
Biomedicine & Pharmacotherapy
·
145
Stem Cell-Based Therapies for Inflammatory Bowel Disease
2022
·
Hua-Min Zhang
, Shuo Yuan
, et al.
·
International Journal of Molecular Sciences
·
60
PDF
Traditional Chinese Medicine and Natural Products: Potential Approaches for Inflammatory Bowel Disease
2022
·
Shuo Yuan
, You Li
, et al.
·
Frontiers in Pharmacology
·
54
PDF
Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment
2022
·
Shuo Yuan
, Qi Wang
, et al.
·
Chinese Medicine
·
49
PDF
Natural products modulate NLRP3 in ulcerative colitis
2023
·
Jia-Chen Xue
, Shuo Yuan
, et al.
·
Frontiers in Pharmacology
·
48
PDF
The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy
2023
·
Shuo Yuan
, Ke-Si Wang
, et al.
·
Biomedicine & Pharmacotherapy
·
35
Biological agents as attractive targets for inflammatory bowel disease therapeutics
2024
·
Jia-Chen Xue
, Xiao-Ting Hou
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
26
Polyphyllin Ⅵ modulates macrophage polarization through autophagy-NLRP3 inflammasome to alleviate inflammatory bowel disease
2025
·
Shuo Yuan
, Bao-Hong Liu
, et al.
·
Phytomedicine
·
21
Autophagy in inflammatory bowel disease: immunization, etiology, and therapeutic potential
2025
·
Zhong-Xing Miao
, Huan Meng
, et al.
·
Frontiers in Immunology
·
12
PDF
Natural Products on Inflammatory Bowel Disease: Role of Gut Microbes
2024
·
Wen-Wen Cheng
, Bao-Hong Liu
, et al.
·
The American Journal of Chinese Medicine
·
10
Corrigendum to “The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy” Biomed. Pharmacother. 165 (2023) 114893
2024
·
Shuo Yuan
, Ke-Si Wang
, et al.
·
Biomedicine & Pharmacotherapy
·
1
Anemoside B4 alleviates DSS-induced colitis by inhibiting CD1d-dependent NLRP3 inflammasome activation in macrophages
2023
·
jiao Li
, Pan Li
, et al.
PDF
Show more works
View as search
Works count:
12
Citation count:
461
H-index:
10
I10-index:
10
Year
Topic
Type
